Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glenn J Hanna, M.D.

Concepts (207)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms13202126062.410 Why?
Oropharyngeal Neoplasms720194212.410 Why?
Carcinoma, Squamous Cell13202039811.880 Why?
Carcinoma, Adenoid Cystic420212621.800 Why?
Mouth Neoplasms720216171.690 Why?
Papillomavirus Infections6201913711.500 Why?
Papillomaviridae7202010801.330 Why?
Salivary Gland Neoplasms220202601.320 Why?
Saliva220198131.020 Why?
Neoplasm Recurrence, Local10202186100.980 Why?
Neoadjuvant Therapy5202124030.880 Why?
Proto-Oncogene Proteins c-bcl-6120192150.730 Why?
Class I Phosphatidylinositol 3-Kinases320198540.710 Why?
Tretinoin120215190.710 Why?
Chromosomes, Human, Pair 3120193360.710 Why?
Genomics6202049210.660 Why?
Quinolones120204480.620 Why?
Skin Neoplasms5202053540.590 Why?
Carcinoma, Neuroendocrine120182940.550 Why?
Carcinoma, Merkel Cell320212280.530 Why?
Iodine Radioisotopes1201810640.520 Why?
Phosphatidylinositol 3-Kinases4202128330.520 Why?
Genes, Tumor Suppressor1201811110.500 Why?
Proto-Oncogene Proteins p21(ras)1202015830.490 Why?
Immunophenotyping2201719150.490 Why?
DNA, Viral1201923410.470 Why?
Hypopharyngeal Neoplasms12011560.460 Why?
Antineoplastic Combined Chemotherapy Protocols52021111150.450 Why?
Residence Characteristics1202119410.440 Why?
Solitary Fibrous Tumors12011740.430 Why?
Immunotherapy5202137930.410 Why?
Survival Analysis62020107660.380 Why?
Hemangiosarcoma120112360.370 Why?
Aged, 80 and over192021593310.370 Why?
Aged2920211622710.350 Why?
Prognosis102021289230.350 Why?
Thyroid Neoplasms2201820820.340 Why?
Survivors1201820330.340 Why?
Breast Diseases120114450.330 Why?
Middle Aged3220212164680.330 Why?
Neoplasm Metastasis6202153910.320 Why?
Antibodies, Viral1201725360.300 Why?
Hematoma120117050.300 Why?
Drug Resistance, Neoplasm3201852650.300 Why?
DNA-Binding Proteins2201999340.260 Why?
Humans5420216866630.260 Why?
Male3220213524650.260 Why?
High-Throughput Nucleotide Sequencing4202035570.250 Why?
Adult2120212114000.250 Why?
Antineoplastic Agents42020138980.240 Why?
Female3220213754590.240 Why?
Treatment Outcome102021609910.220 Why?
Hematopoietic Stem Cell Transplantation1201848830.220 Why?
Hospitalization1202093040.220 Why?
Prospective Studies92020490710.200 Why?
Transcription Factors22019119100.200 Why?
Keratosis12019940.190 Why?
Breast Neoplasms22020191530.190 Why?
Leukoplakia, Oral12019520.190 Why?
Lip120201800.190 Why?
Tumor Burden3202119420.190 Why?
Prostatic Neoplasms12020104390.170 Why?
Osteoradionecrosis12017480.170 Why?
Chloride Channels120182380.170 Why?
Tumor Virus Infections120204510.170 Why?
Neoplasm Proteins3201839720.160 Why?
Mutation82020288480.160 Why?
Genetic Predisposition to Disease12018170710.160 Why?
Hyperbaric Oxygenation120171800.150 Why?
Kidney Transplantation2202040150.150 Why?
Microsatellite Repeats120188270.150 Why?
Frameshift Mutation120184100.150 Why?
Neoplasms52021195380.150 Why?
Cohort Studies52021387320.140 Why?
Oncogenes1202012120.140 Why?
Otorhinolaryngologic Surgical Procedures120183300.140 Why?
Salvage Therapy1202113110.140 Why?
Retrospective Studies122021673200.140 Why?
Young Adult62020560520.130 Why?
Oncogene Proteins120187650.130 Why?
Gene Dosage1201812810.130 Why?
Disease-Free Survival2202171950.120 Why?
Geriatric Assessment1202012540.120 Why?
Precancerous Conditions120199850.120 Why?
Neoplasm Staging42020112650.120 Why?
Radiosurgery1202112710.120 Why?
Myringoplasty12011120.120 Why?
Urban Population1202021440.110 Why?
Drug Synergism1201619390.110 Why?
Interferon-gamma1202032630.110 Why?
Androgen Antagonists1202012700.110 Why?
Adrenal Cortex Hormones1202018090.110 Why?
Middle Ear Ventilation12011850.110 Why?
DNA Copy Number Variations1201917700.110 Why?
Receptor, erbB-21202022120.100 Why?
Rural Population1202021030.100 Why?
Molecular Targeted Therapy2202028840.100 Why?
Lymphatic Metastasis2201530610.100 Why?
Feasibility Studies1201948070.100 Why?
Disease Progression32020132040.100 Why?
Medical Oncology1202018820.090 Why?
TOR Serine-Threonine Kinases2201621030.090 Why?
DNA Mutational Analysis1201844150.090 Why?
Sarcoma1201818220.080 Why?
Graft Rejection1202043140.080 Why?
Sirolimus1201416050.080 Why?
Pilot Projects1201977910.080 Why?
Neoplasms, Radiation-Induced120115920.080 Why?
Incidence32020204960.080 Why?
Genome, Human1202044580.080 Why?
Survival Rate22021136060.070 Why?
Comorbidity12020106480.070 Why?
Biopsy1201868490.070 Why?
Patient Selection1201843810.070 Why?
SEER Program2202015700.070 Why?
Neoplasms, Second Primary120119620.060 Why?
Tumor Suppressor Proteins1201429020.060 Why?
Logistic Models12019138070.060 Why?
Radiotherapy Dosage2202129910.060 Why?
Carcinoma, Ductal, Breast1201110850.060 Why?
Nuclear Proteins1201860090.060 Why?
Combined Modality Therapy3202091140.050 Why?
Clinical Trials as Topic1201780700.050 Why?
Quality of Life12020106760.050 Why?
Methylprednisolone120204030.050 Why?
Mucositis12019920.050 Why?
Hypokalemia120191570.050 Why?
Education, Medical, Graduate1201120990.050 Why?
Cell Transformation, Viral120206750.040 Why?
Virus Integration120203030.040 Why?
Kaplan-Meier Estimate2202069700.040 Why?
Clinical Trials, Phase II as Topic120206160.040 Why?
Signal Transduction22018243510.040 Why?
Jaw12017910.040 Why?
Time-Lapse Imaging120172070.040 Why?
raf Kinases120161200.040 Why?
Maximum Tolerated Dose120199450.040 Why?
Workflow120217340.040 Why?
Genome, Viral120206970.040 Why?
Spheroids, Cellular120173460.040 Why?
Prednisone1202015880.040 Why?
MAP Kinase Kinase Kinases120162810.040 Why?
ras GTPase-Activating Proteins12015990.040 Why?
Clinical Competence1201146320.040 Why?
Sex Distribution1202024360.040 Why?
Quality-Adjusted Life Years1202015610.030 Why?
Receptor, Notch212015920.030 Why?
Diagnosis, Differential12011136030.030 Why?
Radiotherapy, Adjuvant1202018850.030 Why?
Follow-Up Studies12017397370.030 Why?
Lymphocytes, Tumor-Infiltrating1202010520.030 Why?
Sensitivity and Specificity22020150750.030 Why?
Age Distribution1202029630.030 Why?
Postoperative Period1201918610.030 Why?
Cisplatin1202017310.030 Why?
Age of Onset1202033730.030 Why?
Genetic Heterogeneity120167600.030 Why?
Immunity120188910.030 Why?
Gene Rearrangement1201812100.030 Why?
Radiotherapy Planning, Computer-Assisted1202114780.030 Why?
Phylogeny1202028630.030 Why?
In Situ Hybridization, Fluorescence1201826280.030 Why?
Diarrhea1201913390.030 Why?
Income1202017950.030 Why?
Immunologic Factors1202114770.030 Why?
Microfluidic Analytical Techniques120177310.030 Why?
Chemotherapy, Adjuvant1202034860.030 Why?
Receptor, Notch1120155140.030 Why?
Cyclin-Dependent Kinase Inhibitor p16120157440.030 Why?
Analysis of Variance1202066850.030 Why?
Drug Administration Schedule1201951820.030 Why?
Cell Line, Tumor22017172510.030 Why?
Oncogene Proteins, Fusion1201815480.020 Why?
Adolescent12018849570.020 Why?
Cell Culture Techniques1201717770.020 Why?
Tumor Cells, Cultured1201768350.020 Why?
Killer Cells, Natural1201821910.020 Why?
Recurrence1202081980.020 Why?
United States32020655790.020 Why?
Societies, Medical1202037150.020 Why?
Models, Educational120113960.020 Why?
Computational Biology1202036120.020 Why?
Flow Cytometry1201762300.020 Why?
Proto-Oncogene Proteins B-raf1201618850.020 Why?
Cell Cycle Proteins1201834710.020 Why?
Protein Conformation1201441680.020 Why?
Statistics, Nonparametric1201130090.020 Why?
CD8-Positive T-Lymphocytes1201841150.020 Why?
Genotype12020130730.020 Why?
Longitudinal Studies12020134440.020 Why?
Tumor Suppressor Protein p531201529120.020 Why?
Magnetic Resonance Imaging22021331860.020 Why?
Educational Measurement1201112890.020 Why?
Radiography1201470270.020 Why?
Immunohistochemistry12017120950.020 Why?
Smoking1202090290.020 Why?
Sequence Analysis, DNA1201550440.020 Why?
Cytokines1201771470.010 Why?
Base Sequence12015137290.010 Why?
Practice Guidelines as Topic1202076310.010 Why?
Gene Expression Regulation, Neoplastic1201888950.010 Why?
Polymorphism, Single Nucleotide12020152960.010 Why?
Gene Expression Profiling1201596610.010 Why?
Tomography, X-Ray Computed12020204090.010 Why?
Internship and Residency1201153220.010 Why?
Mice12017808030.010 Why?
Animals120171708490.000 Why?
Hanna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (207)
Explore
_
Co-Authors (128)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.